Excessive sleep associated with longer time to return to work among colorectal cancer survivors
the ONA take:
Excessive sleep was associated with a longer time to return to work, a reduction in work time, and increased likelihood to retire among colorectal cancer survivors, according to a recent study published online ahead of print in the journal Supportive Care in Cancer.
For the study, researchers in Australia enrolled 239 colorectal cancer survivors in order to assess associations of health behaviors with return to work outcomes following a colorectal cancer diagnosis among men and women aged 45 to 64 years. Participants were interviewed via telephone and answered questionnaires at 6 and 12 months following diagnosis.
Results showed that participants who reported sleeping 9 or more hours per day were 2.69 times more likely to decrease work time or retire compared with those who slept between 7 and 9 hours per day. Researchers found that excessive sleep was also associated with a longer time to returning to work.
The findings suggest that interventions designed to help colorectal cancer survivors achieve optimal sleep may help them return to work sooner. Further studies are warranted to test those interventions.
Excessive sleep was associated with a longer time to return to work, a reduction in work time, and increased likelihood to retire.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Neuropathic Cancer Pain Linked to Reduced Quality of Life
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|